Aspen Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
4,889
-1,645
-25% -$133K 0.1% 152
2026
Q1
$566K Sell
6,534
-125
-2% -$12K 0.17% 122
2025
Q4
$640K Buy
6,659
+2,670
+67% +$259K 0.19% 112
2025
Q3
$380K Sell
3,989
-45
-1% -$4.14K 0.15% 121
2025
Q2
$352K Sell
4,034
-49
-1% -$4.16K 0.15% 123
2025
Q1
$367K Sell
4,083
-34
-0.8% -$3.04K 0.17% 118
2024
Q4
$329K Sell
4,117
-97
-2% -$8.4K 0.15% 121
2024
Q3
$379K Sell
4,214
-200
-5% -$16.8K 0.18% 114
2024
Q2
$347K Sell
4,414
-230
-5% -$18.9K 0.17% 116
2024
Q1
$405K Sell
4,644
-250
-5% -$21.3K 0.21% 116
2023
Q4
$403K Sell
4,894
-625
-11% -$47.6K 0.23% 100
2023
Q3
$432K Sell
5,519
-200
-3% -$16.7K 0.26% 94
2023
Q2
$504K Hold
5,719
0.3% 88
2023
Q1
$461K Sell
5,719
-342
-6% -$27.9K 0.29% 87
2022
Q4
$471K Sell
6,061
-875
-13% -$70.9K 0.31% 92
2022
Q3
$560K Sell
6,936
-188
-3% -$16.9K 0.37% 84
2022
Q2
$639K Hold
7,124
0.4% 82
2022
Q1
$790K Sell
7,124
-498
-7% -$52.6K 0.41% 81
2021
Q4
$788K Hold
7,622
0.39% 86
2021
Q3
$955K Buy
7,622
+100
+1% +$12.9K 0.51% 66
2021
Q2
$934K Buy
7,522
+50
+0.7% +$6.28K 0.49% 75
2021
Q1
$883K Sell
7,472
-40
-0.5% -$4.69K 0.49% 73
2020
Q4
$880K Sell
7,512
-50
-0.7% -$5.5K 0.52% 68
2020
Q3
$786K Buy
7,562
+125
+2% +$12.6K 0.52% 65
2020
Q2
$682K Sell
7,437
-230
-3% -$22.1K 0.49% 67
2020
Q1
$691K Buy
7,667
+200
+3% +$21.3K 0.6% 53
2019
Q4
$847K Sell
7,467
-150
-2% -$16.5K 0.53% 66
2019
Q3
$827K Hold
7,617
0.55% 64
2019
Q2
$742K Hold
7,617
0.49% 71
2019
Q1
$694K Hold
7,617
0.48% 69
2018
Q4
$693K Hold
7,617
0.56% 60
2018
Q3
$749K Sell
7,617
-20
-0.3% -$1.85K 0.5% 64
2018
Q2
$654K Buy
7,637
+485
+7% +$40.5K 0.45% 68
2018
Q1
$574K Hold
7,152
0.41% 76
2017
Q4
$578K Hold
7,152
0.41% 74
2017
Q3
$556K Hold
7,152
0.41% 70
2017
Q2
$635K Hold
7,152
0.48% 58
2017
Q1
$576K Sell
7,152
-144
-2% -$11.2K 0.43% 62
2016
Q4
$520K Hold
7,296
0.39% 66
2016
Q3
$630K Buy
7,296
+35
+0.5% +$3.05K 0.5% 51
2016
Q2
$630K Buy
7,261
+1,250
+21% +$101K 0.52% 48
2016
Q1
$451K Hold
6,011
0.41% 61
2015
Q4
$462K Hold
6,011
0.46% 62
2015
Q3
$402K Sell
6,011
-500
-8% -$36.8K 0.39% 69
2015
Q2
$482K Sell
6,511
-500
-7% -$38.2K 0.4% 66
2015
Q1
$547K Buy
7,011
+156
+2% +$11.8K 0.44% 61
2014
Q4
$495K Sell
6,855
-25
-0.4% -$1.74K 0.42% 70
2014
Q3
$426K Sell
6,880
-1,690
-20% -$107K 0.36% 74
2014
Q2
$546K Buy
8,570
+480
+6% +$29.2K 0.33% 84
2014
Q1
$498K Hold
8,090
0.32% 83
2013
Q4
$464K Buy
8,090
+170
+2% +$9.64K 0.31% 91
2013
Q3
$422K Hold
7,920
0.3% 85
2013
Q2
$408K Buy
+7,920
New +$391K 0.28% 85

Other funds holding MDT

Aspen Investment Management's MDT Position: Q2 2026 in Review

Aspen Investment Management reduced its Medtronic (MDT) stake by 25% in Q2 2026, selling an estimated $133K and leaving 4,889 shares worth $382K. The position accounts for 0.1% of the portfolio, ranked #152.

Aspen Investment Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $955K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Aspen Investment Management held 4,889 shares of Medtronic worth $382K as of Q2 2026.
  • Aspen Investment Management sold 1,645 Medtronic shares in Q2 2026, an estimated $133K.
  • Medtronic made up 0.1% of Aspen Investment Management's portfolio in Q2 2026, its #152 holding.
  • Aspen Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Aspen Investment Management's Medtronic position peaked at $955K in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.